Routine assessments of disease activity and functional status are a key part of high-quality rheumatologic care. The ACR endorses five rheumatoid arthritis (RA) disease activity measures, as well as three RA functional status assessment measures for use in routine clinical practice.
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures
• Appendix
2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis
• Appendix
Rheumatoid Arthritis Disease Activity Calculators (includes the five disease activity measures)
What This Means for You
The ACR is using the results of this work to update its quality measures in a variety of payment programs. Providers who report through the Merit-Based Incentive Payment System (MIPS) will see changes to the following reportable quality measures for the 2020 performance year (January 1, 2020 – December 31, 2020).
- Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity (QPP 177) (Note: PAS is no longer an accepted tool for assessing disease activity. This does not apply to PAS-II.)
- Rheumatoid Arthritis (RA): Functional Status Assessment (QPP 178) (Note: The acceptable tools for assessing functional status have been narrowed to those identified through this work – PROMIS PF10a, HAQ-II and MDHAQ.)
DAS28 CRP / DAS28 ESR
For more information about these measures, please contact P.L. C.M. van Riel.
RAPID 3
The MDHAQ™ and the RAPID3™ are protected by copyright and owned by Theodore Pincus, MD. All requests for permission must be made in writing, in advance of intended use. For more information about these measures, please contact Theodore Pincus, MD.